Vessey Rupert
CIK 0001677618
EVP, Research & Early Dev.Director
Filings
12
Latest Mar 2, 2026
Issuers covered
3
Showing
12 of 12
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | -6.3% | -10.2% | +1.5% | -10.2% |
| 90 days | 3 | 33% | -0.5% | -4.6% | +7.7% | -4.6% |
| 180 days | 3 | 33% | +5.1% | -3.9% | +23.1% | -3.9% |
| 365 days | 3 | 100% | +13.9% | +3.7% | +34.4% | +3.7% |
Issuers
Companies where Vessey Rupert has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BMY | Bristol Myers Squibb Co | 7 | May 4, 2023 |
| TECH | Bio-Techne Corp | 4 | Nov 3, 2025 |
| GENB | Generate Biomedicines, Inc. | 1 | Mar 2, 2026 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|